These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 2906393

  • 21. A new beta 2-adrenoceptor agonist with alpha 1-adrenoceptor blocking properties.
    Olsson OA, Ahlquist B, Gustafsson B.
    Acta Pharmacol Toxicol (Copenh); 1981 Apr; 48(4):340-8. PubMed ID: 6121453
    [Abstract] [Full Text] [Related]

  • 22. Pharmacodynamic profile of the selective beta 1-adrenoceptor antagonist bisoprolol.
    Harting J, Becker KH, Bergmann R, Bourgois R, Enenkel HJ, Fuchs A, Jonas R, Lettenbaur H, Minck KO, Schelling P.
    Arzneimittelforschung; 1986 Feb; 36(2):200-8. PubMed ID: 2870720
    [Abstract] [Full Text] [Related]

  • 23. Influence of epithelium on beta-adrenoceptor desensitization of guinea pig tracheal smooth muscle.
    Boskabady MH, Aslani MR.
    Respir Physiol Neurobiol; 2007 Apr 16; 156(1):69-78. PubMed ID: 16973424
    [Abstract] [Full Text] [Related]

  • 24. Evidence that prazosin disturbs isoprenaline positive inotropic action in the guinea pig heart papillary muscle.
    Kocić I.
    Pol J Pharmacol; 1996 Apr 16; 48(4):447-52. PubMed ID: 9112686
    [Abstract] [Full Text] [Related]

  • 25. Effects of a new 2-piperazinotetralin on alpha-1 and alpha-2 adrenergic receptors in isolated rat vas deferens.
    Mutafova-Yambolieva V, Staneva-Stoytcheva D, Ivanov D.
    Methods Find Exp Clin Pharmacol; 1985 Jun 16; 7(6):291-6. PubMed ID: 2997557
    [Abstract] [Full Text] [Related]

  • 26. Pharmacological effects of an aldehyde type alpha/beta-adrenoceptor blocking agent with vasodilating properties.
    Chiu CC, Lin YT, Tsai CH, Liang JC, Chiang LC, Wu JR, Chen IJ, Yeh JL.
    Gen Pharmacol; 2000 Jun 16; 34(6):391-400. PubMed ID: 11483288
    [Abstract] [Full Text] [Related]

  • 27. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.
    Yamaura T, Kase N, Kita H, Uematsu T.
    Arzneimittelforschung; 1986 Jun 16; 36(1):29-34. PubMed ID: 3754142
    [Abstract] [Full Text] [Related]

  • 28. Pharmacology of amezinium, a novel antihypotensive drug. III. Studies on the mechanism of action.
    Lenke D, Gries J, Kretzschmar R.
    Arzneimittelforschung; 1981 Jun 16; 31(9a):1558-65. PubMed ID: 7197970
    [Abstract] [Full Text] [Related]

  • 29. [On the pharmacology of the alpha-receptor blocker BE 2254 (HEAT) (author's transl)].
    Heinz N, Hofferber E.
    Arzneimittelforschung; 1980 Jun 16; 30(12):2135-9. PubMed ID: 6111325
    [Abstract] [Full Text] [Related]

  • 30. Mechanism of the hypotensive effect of a new beta-adrenergic blocking drug, arotinolol (S-596) in anesthetized rabbits.
    Nakahara H, Nakazawa M, Tsukada T, Imai S.
    Arch Int Pharmacodyn Ther; 1985 Oct 16; 277(2):253-63. PubMed ID: 2415080
    [Abstract] [Full Text] [Related]

  • 31. In vitro evaluation of the beta-blocking and electrophysiological properties of mepindolol.
    Amerini S, Bini R, Cerbai E, Ledda F, Mantelli L, Mugelli A.
    Arch Int Pharmacodyn Ther; 1986 Aug 16; 282(2):276-87. PubMed ID: 2876690
    [Abstract] [Full Text] [Related]

  • 32. Calcium entry blocking, beta 1-adrenoceptor blocking and hypotensive effects of YM-16151-4.
    Shibasaki K, Uchida W, Matsuda Y, Asano M.
    Arch Int Pharmacodyn Ther; 1991 Aug 16; 313():140-50. PubMed ID: 1687772
    [Abstract] [Full Text] [Related]

  • 33. Hypotensive action and alpha-adrenolytic properties of a new dopaminergic agonist, CU 32-085, in the rat.
    Morales-Olivas FJ, Palop V, Rubio E, Esplugues J.
    Arch Int Pharmacodyn Ther; 1984 Nov 16; 272(1):71-8. PubMed ID: 6151381
    [Abstract] [Full Text] [Related]

  • 34. Anaesthetised normotensive rats for the detection of hypotensive activity of a beta-adrenoceptor antagonist and other antihypertensive agents.
    Chu D, Hofmann A, Stürmer E.
    Arzneimittelforschung; 1978 Nov 16; 28(11):2093-7. PubMed ID: 40564
    [Abstract] [Full Text] [Related]

  • 35. Central action of beta-adrenoceptor antagonists on blood pressure after acute administration in rats.
    Davy M, Midol-Monnet M, Heimburger M, Wepierre J, Cohen Y.
    J Pharmacol; 1986 Nov 16; 17(1):28-36. PubMed ID: 2872366
    [Abstract] [Full Text] [Related]

  • 36. Derivatives related to betaxolol with alpha- and beta-adrenergic activities.
    Leclerc G, Decker N, Schwartz J.
    Arzneimittelforschung; 1985 Nov 16; 35(9):1357-67. PubMed ID: 2867769
    [Abstract] [Full Text] [Related]

  • 37. A highly selective beta1-adrenergic blocker with partial beta2-agonist activity derived from ferulic acid, an active component of Ligusticum wallichii Franch.
    Wu BN, Huang YC, Wu HM, Hong SJ, Chiang LC, Chen IJ.
    J Cardiovasc Pharmacol; 1998 May 16; 31(5):750-7. PubMed ID: 9593075
    [Abstract] [Full Text] [Related]

  • 38. [Action of alpha- and beta-adrenergic blockaders on the effects of isadrin and noradrenaline in narcotized rats].
    Noravian OS, Abakian OM.
    Zh Eksp Klin Med; 1978 May 16; 18(1):57-62. PubMed ID: 25545
    [No Abstract] [Full Text] [Related]

  • 39. Antihypertensive and adrenergic receptor blocking properties of the enantiomers of medroxalol.
    Cheng HC, Reavis OK, Grisar JM, Claxton GP, Weiner DL, Woodward JK.
    Life Sci; 1978 May 16; 27(25-26):2529-34. PubMed ID: 6111723
    [No Abstract] [Full Text] [Related]

  • 40. Enantiomers of 8-(3-tert-butylamino-2-hydroxypropoxy)-3,4-dihydro-3-oxo-2H- (1,4)benzothiazine: racemic resolution, chiral synthesis and biological activity.
    Schiaffella F, Fringuelli R, Cecchetti V, Fravolini A, Angeli P, Marucci G.
    Farmaco; 1990 Dec 16; 45(12):1299-307. PubMed ID: 1982489
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.